Roche Phesgo 1200/600 mg Injection (Pertuzumab/Trastuzumab), Dosage Form: Vial, 15 ml at Rs 195000/vial in Tiruvannamalai
Phesgo™ pertuzumab, trastuzumab and hyaluronidase-zzxf
PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) | A Treatment for HER2-Positive Breast Cancer
画像配置エリア “PHESGO® combination for subcutaneous injection MA / IN”
Phesgo™ pertuzumab, trastuzumab and hyaluronidase-zzxf
Practical Considerations for Implementation of Biosimilars in Oncology
PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) | A Treatment for HER2-Positive Breast Cancer
PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) Overview
Phesgo®
画像配置エリア “PHESGO® combination for subcutaneous injection MA / IN”
Last Review Status/Date:
Phesgo 600mg/600mg/20.000 Units S.C. Solution For Injection 10 ml | null
PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) | A Treatment for HER2-Positive Breast Cancer
Dosing & Administration | PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx)
PHESGO- pertuzumab, trastuzumab, and hyaluronidase-zzxf injection, solution
PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) | A Treatment for HER2-Positive Breast Cancer
Phesgo (pertuzumab/trastuzumab/hyaluronidase-zzxf)
PHESGO- pertuzumab, trastuzumab, and hyaluronidase-zzxf injection, solution
Phesgo 600mg at Rs 250000/vial in Vadodara | ID: 2853117162462
Phesgo™ (pertuzumab, trastuzumab and hyaluronidase-zzxf)
AFD-GN20HER055_Perjeta_Nurse_Admin_v14_end_matter (1)
Dosing & Administration | PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx)
Dosing & Administration | PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx)
PHESGO® (pertuzumab / trastuzumab / hyaluronidase-zzfx) | A Treatment for HER2-Positive Breast Cancer
